Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review

OBJECTIVES: To examine the evidence derived from randomized controlled clinical trials on the efficacy and safety of omalizumab compared to placebo in controlling symptoms of chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU). DATA SOURCE: The electronic databases PubMed, Medline,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:World Allergy Organ J
Prif Awduron: Carrillo, Diana C, Borges, Mario Sanchez, García, Elizabeth, Egea, Eduardo, Serrano, Carlos D
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2014
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4280746/
https://ncbi.nlm.nih.gov/pubmed/25566332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40413-014-0050-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg